Pre-fibrotic/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease.

G Jeryczynski; J Thiele; B Gisslinger; Albert Wölfler; M Schalling; A Gleiß; S Burgstaller; V Buxhofer-Ausch; T Sliwa; E Schlögl; K Geissler; MT Krauth; A Nader; M Vesely; I Simonitsch-Klupp; L Müllauer; Christine Beham-Schmid; H Gisslinger

doi:10.1002/ajh.24788

Pre-fibrotic/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease.

G Jeryczynski
, J Thiele
, B Gisslinger
, Albert Wölfler
, M Schalling
, A Gleiß
, S Burgstaller
, V Buxhofer-Ausch
, T Sliwa
, E Schlögl
, K Geissler
, MT Krauth
, A Nader
, M Vesely
, I Simonitsch-Klupp
, L Müllauer
, Christine Beham-Schmid
, H Gisslinger

Research output: Contribution to journal › Research article

57 Citations (Web of Science)

Original language	English
Journal	American Journal of Hematology
DOIs	https://doi.org/10.1002/ajh.24788
Publication status	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Branches of science

301 Medical-Theoretical Sciences, Pharmacy
302 Clinical Medicine

Research Fields

Cancer Research

DOI

10.1002/ajh.24788

Links

Cite this

Jeryczynski, G., Thiele, J., Gisslinger, B., Wölfler, A., Schalling, M., Gleiß, A., Burgstaller, S., Buxhofer-Ausch, V., Sliwa, T., Schlögl, E., Geissler, K., Krauth, MT., Nader, A., Vesely, M., Simonitsch-Klupp, I., Müllauer, L., Beham-Schmid, C., & Gisslinger, H. (2017). Pre-fibrotic/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease. American Journal of Hematology. https://doi.org/10.1002/ajh.24788

@article{70b88c51e2194f18b9fac57ab3ff4d11,

title = "Pre-fibrotic/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease.",

author = "G Jeryczynski and J Thiele and B Gisslinger and Albert W{\"o}lfler and M Schalling and A Glei{\ss} and S Burgstaller and V Buxhofer-Ausch and T Sliwa and E Schl{\"o}gl and K Geissler and MT Krauth and A Nader and M Vesely and I Simonitsch-Klupp and L M{\"u}llauer and Christine Beham-Schmid and H Gisslinger",

year = "2017",

doi = "10.1002/ajh.24788",

language = "English",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "John Wiley and Sons Inc",

}

Jeryczynski, G, Thiele, J, Gisslinger, B, Wölfler, A, Schalling, M, Gleiß, A, Burgstaller, S, Buxhofer-Ausch, V, Sliwa, T, Schlögl, E, Geissler, K, Krauth, MT, Nader, A, Vesely, M, Simonitsch-Klupp, I, Müllauer, L, Beham-Schmid, C & Gisslinger, H 2017, 'Pre-fibrotic/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease.', American Journal of Hematology. https://doi.org/10.1002/ajh.24788

TY - JOUR

T1 - Pre-fibrotic/early primary myelofibrosis vs. WHO-defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease.

AU - Jeryczynski, G

AU - Thiele, J

AU - Gisslinger, B

AU - Wölfler, Albert

AU - Schalling, M

AU - Gleiß, A

AU - Burgstaller, S

AU - Buxhofer-Ausch, V

AU - Sliwa, T

AU - Schlögl, E

AU - Geissler, K

AU - Krauth, MT

AU - Nader, A

AU - Vesely, M

AU - Simonitsch-Klupp, I

AU - Müllauer, L

AU - Beham-Schmid, Christine

AU - Gisslinger, H

PY - 2017

Y1 - 2017

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000407018100024

UR - https://pubmed.ncbi.nlm.nih.gov/28543356

U2 - 10.1002/ajh.24788

DO - 10.1002/ajh.24788

M3 - Research article

C2 - 28543356

SN - 0361-8609

JO - American Journal of Hematology

JF - American Journal of Hematology

ER -